SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea Holdings
If you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 27, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fortrea Holdings Inc. ('Fortrea' or the 'Company') (NASDAQ: FTRE) and reminds investors of the August 1, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/6455/257017_63207dd6d4a29804_001full.jpg ]
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to contribute to the Company's 2025 earnings; (2) Fortrea overstated the cost savings it would likely achieve by exiting the TSAs; (3) as a result, the Company's previously announced EBITDA targets for 2025 were inflated; (4) accordingly, the viability of the Company's post-Spin-Off business model, as well as its business and/or financial prospects, were overstated; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.
On September 25, 2024, the investment bank Jefferies published a report (the 'Jefferies Report') downgrading Fortrea from buy to hold. Among other things, the Jefferies Report cited perceived weaknesses in the Company's business model as a CRO amid pressure on biotechnology funding and suggested that the cost savings Fortrea expects to achieve by exiting the TSAs are 'not as material as [o]ne [m]ight think,' stating that 'IT infrastructure costs to exit the TSAs are already non-GAAPed out of adjusted EBITDA. Thus, once TSAs are exited, Fortrea will just be replacing TSA costs with internal operating costs.'
On this news, Fortrea's stock price fell $2.73 per share, or 12.29%, to close at $19.48 per share on September 25, 2024.
Then, on December 6, 2024, market analyst Baird Equity Research ('Baird') downgraded Fortrea to neutral from outperform after the Company abruptly cancelled two scheduled conferences. A Baird analyst said that 'given our ongoing concerns around the sector, Fortrea's choppy history post spin, and lack of clarity on the abrupt communications course change, we cannot recommend an actionable investment (buy or sell)[.]'
On this news, Fortrea's stock price fell $1.90 per share, or 8.06%, to close at $21.67 per share on December 6, 2024.
Finally, on March 3, 2025, Fortrea announced its fourth quarter and full year 2024 financial results, disclosing that its 'targeted revenue and adjusted EBITDA trajectories for 2025 [were] not in line with [its] prior expectations.' Specifically, in an earnings call held that same day, Fortrea revealed that the Company's Pre-Spin projects are 'late in their life cycle [and] have less revenue and less profitability than expected for 2025" and that 'post-spin work is not coming on fast enough to offset the pre-spin contract economics.' The Company also said this 'older versus newer mix issue will continue to negatively impact Fortrea's financial performance during 2025.'
On this news, Fortrea's stock price fell $3.47 per share, or 25.05%, to close at $10.38 per share on March 3, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Fortrea's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Fortrea class action, go to www.faruqilaw.com/FTRE or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257017
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
3 Reasons to Buy BULZ, and 4 Reasons Not To
The so-called FANG stocks and most of their peers have been the only names to produce market-beating gains in recent years. Investors looking for an easy way to get more out of their collective performance have had relatively few options. This instrument, however, has a couple of serious downsides that might not make it worth adding to your portfolio. 10 stocks we like better than MicroSectors Solactive Fang Innovation 3x Leveraged ETNs Due June 28 › Got guts? And, do you want market-beating returns? You typically need the former to get the latter, of course, since a greater reward requires taking on greater risk. And, you must also take the right risks ... ones that pay off rather than chew up your capital. Fortunately, just applying a little common sense and being patient will go a long way in this regard. With that as the backdrop, investors looking to spice up their overall returns without making their portfolio more complicated might want to take a look at the MicroSectors Solactive FANG Innovation 3x Leveraged ETN (NYSEMKT: BULZ). This exchange-traded note (ETN) is not for everyone -- but it may well be a good fit for you. There's a good chance you've never heard of it; plenty of investors haven't. This fund's $1.5 billion in assets is a pittance compared to the size of more familiar exchange-traded funds (ETFs) like the SPDR S&P 500 ETF Trust (NYSEMKT: SPY) or the Invesco QQQ Trust (NASDAQ: QQQ), underscoring investors' lack of interest in what it offers. Don't dismiss the prospect simply because it's not drawing a huge crowd, however. That doesn't mean it doesn't have a potential place in your portfolio. Cutting straight to the chase, just as the name suggests, the MicroSectors Solactive FANG Innovation 3x Leveraged ETN is an exchange-traded instrument that on any given day moves three times as much as the so-called FANG stocks like Amazon, Alphabet, Meta Platforms, and others collectively do. It's not just the original FANG names, however. The Solactive FANG Innovation Index that it is meant to mirror also includes the FANG companies' most important technology peers, such as Nvidia, Palantir Technologies, and Broadcom. All told, the index and fund reflect the daily collective performance of 15 of the market's hottest stocks of its most important companies of late, multiplied by a factor of three. These are mostly tech names, of course, operating within high-demand industries like artificial intelligence (AI), mobile devices, and cloud computing, just to name a few. One key difference between BULZ and leveraged ETFs? It's not weighted by its constituent companies' market capitalizations. It's an equal-weighted investment, meaning each constituent's contribution to the ETN's net daily movement isn't crimped or augmented just by that company's smaller or bigger size. This is arguably a healthier balance. And if you're wondering, an ETN is an exchange-traded note. They trade just like ETFs, and for all practical investing purposes, can be seen as the same. The big difference is that an ETN doesn't technically hold the stocks in question. The ETN's issuer does, while its manager makes any buying and selling decisions. In this instance, the Bank of Montreal holds the underlying assets that are managed by a third-party asset manager called REX Shares. It's a broadly compelling prospect. However, there are three very specific reasons to own a piece of this exchange-traded note. One of the chief complaints about the recent market environment is that only a handful of stocks have produced most of the marketwide gains. Owning each one of them individually could require an overwhelming amount of effort, yet owning an instrument like QQQ or an S&P 100 index fund could still saddle you with too many laggards. The MicroSectors Solactive FANG Innovation 3x Leveraged ETN is one of the few ways to own most all the best names without owning too many underperformers. That being said, if an investor is specifically looking for stocks like Nvidia, Palantir, and Amazon, it's a reasonably safe bet that they're also looking for above-average performance. BULZ offers even more of this performance than they could ever achieve simply by buying and holding these tickers alone. REX uses derivatives to amplify the daily moves these stocks are making, by a factor of three. If these tickers are on the rise, BULZ is rising much, much more. Finally, another one of the top complaints about recent market dynamics is how a small handful of high-performing stocks like Apple and Nvidia have caused indexes (and therefore, index funds) to become top-heavy. That just means the market's very biggest companies are now overrepresented. Should these individual mega-stocks start to peel back from their big gains, funds and indexes could take an exaggerated hit. The MicroSectors Solactive FANG Innovation 3x Leveraged ETN is reasonably well-protected from such an exaggerated setback, though. The underlying Solactive FANG Innovation Index is rebalanced to an equal weighting every month, curbing much of the potential for excessive volatility. That being said, there are even more downsides to consider before stepping into this particular leveraged fund. Volatility is fine as long as it's working in your favor. Things dramatically change, however, when the market's darlings start to lose ground, and you're watching your positions lose value three times as quickly. This sort of loss can create a panic, and investors don't always make the best decisions under duress. The idea behind a FANG-focused fund that also includes most of the market's other hottest stocks makes sense right now because it's working -- these are the market's must-have names. But nothing lasts forever. There may come a time when these stocks aren't leading the marketwide bullish charge. While REX can swap the ETN's current holdings with more relevant and innovative names in the future, there's no assurance it will do so to your satisfaction. Although it's a pittance compared to its potential upside, by index fund standards, the MicroSectors Solactive FANG Innovation 3x Leveraged ETN costs more than average to operate. Its expense ratio is in the ballpark of 1% of its assets, shaving down your annual net gains by that amount. Given that it's the issuer and arguably has the most to gain by attracting new investors, you'd expect the Bank of Montreal to be the ETN's biggest cheerleader. But, nope. In its own prospectus on BULZ, the bank warns that its exchange-traded notes are "not intended to be 'buy and hold' investments." It explains, "If you invest in the notes, you should continuously monitor your holding of the notes and make investment decisions at least on each Index business day, or even intraday." In a similar time frame-minded sense, know that this particular ETN has a planned expiration date of June 28, 2041, but Bank of Montreal could also choose to shut it down anytime between now and then. The downside certainly seems to outweigh the upside. And for most investors, there arguably is too much risk here to justify what's admittedly an impressive degree of potential reward. If you can read the prospectus's warning for what it actually likely is, though -- boilerplate language meant to discourage inexperienced investors from becoming a legal liability -- there's a limited-use case to be made here. Although the Bank of Montreal appears to be discouraging long-term investors while encouraging short-term-minded ones, short-term trading is already difficult to do well; this ETN could make it even trickier. True buy-and-hold investors willing to stick with these 15 stocks for years on end, despite how they perform in the meantime, conversely, would be even more rewarded for their patience with a position in BULZ. Just don't get crazy. Even these committed investors will want to keep any position in the MicroSectors Solactive FANG Innovation 3x Leveraged ETN relatively modest, as a means of limiting their risk. Before you buy stock in MicroSectors Solactive Fang Innovation 3x Leveraged ETNs Due June 28, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and MicroSectors Solactive Fang Innovation 3x Leveraged ETNs Due June 28 wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $697,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $939,655!* Now, it's worth noting Stock Advisor's total average return is 1,045% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. James Brumley has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, Nvidia, and Palantir Technologies. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. 3 Reasons to Buy BULZ, and 4 Reasons Not To was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
10 minutes ago
- Yahoo
Why Micron Technology Rallied 30.5% in June
Micron handily beat earnings expectations and gave strong forward guidance. However, its stock had rallied hard all month prior to a post-earnings "sell the news" dip. Micron looks historically expensive, but artificial intelligence (AI) may still make the stock a buy. 10 stocks we like better than Micron Technology › Shares of memory giant Micron Technology (NASDAQ: MU) rallied 30.5% in June, according to data from S&P Global Market Intelligence. Micron reported earnings late in the month that handily outpaced analyst expectations. Even though the stock fell in the aftermath, there had already been a huge run-up into the earnings report, reflecting a pre-earnings surge in memory pricing. In its fiscal third quarter, Micron saw revenue grow 36.6% year over year to $9.3 billion, with adjusted non-GAAP (generally accepted accounting principles) earnings per share more than tripling to $1.91, each well ahead of analyst expectations. In addition, Micron forecast an above-consensus $10.7 billion in revenue for the next quarter, along with $2.50 in adjusted EPS, amounting to quarter-over-quarter growth rates of 15% and 31%, respectively. The stellar results have come about due to artificial intelligence (AI), which is no surprise. Micron reported a near-50% quarterly increase in its high-bandwidth memory (HBM) used in AI training. Micron got a bit of a late start on HBM, but is rapidly catching up to market leader SK Hynix, while Samsung, the leader in traditional DRAM memory, struggles with its HBM technology. Micron management reiterated it was on track to achieve the same overall market share in HBM, as its current overall DRAM share by the second half of the year, and that it had now qualified its HBM solutions with four customers across AI GPUs and ASICs. Investors had expected good news, especially as older-generation DDR4 prices skyrocketed over the last couple of months, while HBM prices remain fixed and profitable based on prenegotiated contracts. The DDR4 price spike won't last, however, because it's due to Micron and other memory players "end of life-ing" those DDR4 products for newer DDR5. Still, the long-term outlook for DRAM memory appears positive, given the massive demand coming from artificial intelligence systems. Micron now trades at 22 times earnings, but since the company has been so cyclical in the past, it has usually been better to value Micron based on book value. With the stock now at 2.75 times book value, that's at the high end of its historical range. That said, things are arguably looking better for Micron than ever before in the age of AI. HBM pricing is more stable than traditional memory and is in perpetual short supply, given that HBM is a primary bottleneck for AI systems today. Furthermore, Micron has surged ahead of its two main rivals in process technology, with management noting "excellent progress" on its upcoming 1-gamma node. So while Micron's shares may look fully valued, the stock may re-rate higher if it can sustain multiple years of better profitability and less cyclicality. Before you buy stock in Micron Technology, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Micron Technology wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $697,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $939,655!* Now, it's worth noting Stock Advisor's total average return is 1,045% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Billy Duberstein and/or his clients has positions in Micron Technology. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Micron Technology Rallied 30.5% in June was originally published by The Motley Fool
Yahoo
11 minutes ago
- Yahoo
TSLA: JPMorgan Sees 'Material Risk' To Tesla, Shares Could Fall Over 60%
July 2 - J.P. Morgan (NYSE:JPM) warns Tesla (NASDAQ:TSLA) shares could slide more than 60%, as the EV maker's recent political distractions and soft sales weigh on demand. Tesla stock fell about 5% Tuesday, extending a year?to?date decline of over 25%. Analyst Ryan Brinkman cites material risks to delivery forecasts after Q1's 13% year?on?year drop, which channel checks suggest may deepen to a 19% fall in Q2. He now expects deliveries of 360,000 vehicles, below the 392,000 consensus. Brinkman trimmed his Q2 EPS estimate to $0.42 from $0.48, and cut full?year guidance to $1.75 from $2.07, both under Wall Street's respective forecasts of $0.45 and $1.87. The analyst retained his Underweight rating with a $115 price target, implying roughly a 62% downside over the next 12 months. By contrast, the Street's average target of $291 still suggests a modest overvaluation of about 3%, with a consensus Hold rating. Brinkman points to waning federal subsidies and a challenging macro environment as headwinds, even as Musk prepares to unveil a lower?cost model. Investors will be watching Tesla's Q2 delivery report closely for signs of a sustained recovery. This article first appeared on GuruFocus.